These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2031609)

  • 41. Urinary oxalate to creatinine ratios in healthy Turkish schoolchildren.
    Dursun I; Çelik İ; Poyrazoglu HM; Köse K; Tanrıkulu E; Sahin H; Yılmaz K; Öztürk A; Yel S; Gündüz Z; Düşünsel R
    Ren Fail; 2017 Nov; 39(1):146-152. PubMed ID: 27846788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The determination of oxalate in urine and plasma by high performance liquid chromatography.
    Fry ID; Starkey BJ
    Ann Clin Biochem; 1991 Nov; 28 ( Pt 6)():581-7. PubMed ID: 1776808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary hyperoxaluria type 1 in Tunisian children.
    Gargah T; Khelil N; Youssef G; Karoui W; Lakhoua MR; Abdelmoula J
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):385-90. PubMed ID: 22382246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.
    Tomson CR; Channon SM; Parkinson IS; Morley AR; Lennard TW; Parrott NR; Laker MF
    J Clin Pathol; 1988 Oct; 41(10):1107-13. PubMed ID: 3192733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High incidence of hyperoxaluria in generalized peroxisomal disorders.
    van Woerden CS; Groothoff JW; Wijburg FA; Duran M; Wanders RJ; Barth PG; Poll-The BT
    Mol Genet Metab; 2006 Aug; 88(4):346-50. PubMed ID: 16621644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
    Monico CG; Persson M; Ford GC; Rumsby G; Milliner DS
    Kidney Int; 2002 Aug; 62(2):392-400. PubMed ID: 12110000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypical features of primary hyperoxaluria in end-stage renal disease.
    Absy MM
    Am J Nephrol; 1991; 11(4):301-4. PubMed ID: 1799188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycolate determination detects type I primary hyperoxaluria in dialysis patients.
    Marangella M; Petrarulo M; Bianco O; Vitale C; Finocchiaro P; Linari F
    Kidney Int; 1991 Jan; 39(1):149-54. PubMed ID: 2002628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [24-hour urinary oxalate excretion in healthy children and in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Wawrzyszuk M; Zajaczkowska M
    Pol Merkur Lekarski; 2008; 24 Suppl 4():76-9. PubMed ID: 18924510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Scheinman JI; Voziyan PA; Belmont JM; Chetyrkin SV; Kim D; Hudson BG
    Urol Res; 2005 Nov; 33(5):368-71. PubMed ID: 16292584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma and urine measurements for monitoring of treatment in the primary hyperoxaluric patient.
    Kasidas GP
    Nephrol Dial Transplant; 1995; 10 Suppl 8():8-10. PubMed ID: 8592630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxalic acid concentration in serum measured by isotopic clearance technique. Experience in hyper- and normo-oxaluric subjects.
    Prenen JA; Mees EJ; Boer P; Endeman HJ; Ephraim KH
    Proc Eur Dial Transplant Assoc; 1979; 16():566-70. PubMed ID: 549000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxalate retention in chronic renal failure: tubular vs glomerular diseases.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Clin Nephrol; 1989 Aug; 32(2):87-95. PubMed ID: 2788548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential studies of oxalate dynamics in primary hyperoxaluria.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1983 Dec; 65(6):627-33. PubMed ID: 6627848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re: The Effects of the Inactivation of Hydroxyproline Dehydrogenase on Urinary Oxalate and Glycolate Excretion in Mouse Models of Primary Hyperoxaluria.
    Assimos DG
    J Urol; 2020 May; 203(5):876. PubMed ID: 32073946
    [No Abstract]   [Full Text] [Related]  

  • 60. Fractional oxalate clearance in subjects with normal and impaired renal function.
    Boer P; Prenen JA; Koomans HA; Dorhout Mees EJ
    Nephron; 1985; 41(1):78-81. PubMed ID: 4033845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.